La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Vaishali Pharma Gestion
Gestion contrôle des critères 2/4
Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.
Informations clés
Hemanth Pathak
Directeur général
n/a
Rémunération totale
| Pourcentage du salaire du PDG | n/a |
| Durée du mandat du directeur général | 4.4yrs |
| Propriété du PDG | n/a |
| Durée moyenne d'occupation des postes de direction | 4.4yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 5.7yrs |
Mises à jour récentes de la gestion
Recent updates
A Piece Of The Puzzle Missing From Vaishali Pharma Limited's (NSE:VAISHALI) 27% Share Price Climb
Sep 13
The Market Lifts Vaishali Pharma Limited (NSE:VAISHALI) Shares 26% But It Can Do More
Jul 05Here's Why Vaishali Pharma (NSE:VAISHALI) Has Caught The Eye Of Investors
Jan 17Vaishali Pharma Limited's (NSE:VAISHALI) Shares Leap 30% Yet They're Still Not Telling The Full Story
Dec 18Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?
Dec 11We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease
Oct 04With EPS Growth And More, Vaishali Pharma (NSE:VAISHALI) Makes An Interesting Case
Feb 04Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly
Dec 10We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease
Aug 20Should You Be Adding Vaishali Pharma (NSE:VAISHALI) To Your Watchlist Today?
May 19These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well
Feb 10A Look At The Intrinsic Value Of Vaishali Pharma Limited (NSE:VAISHALI)
Aug 17A Look At The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)
May 17Are Vaishali Pharma Limited's (NSE:VAISHALI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 17Calculating The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)
Feb 15Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?
Jan 19
Are Vaishali Pharma Limited's (NSE:VAISHALI) Mixed Financials Driving The Negative Sentiment?
Nov 23PDG
Hemanth Pathak (63 yo)
4.4yrs
Titularisation
Mr. Hemanth Damodar Pathak serves as Chief Executive Officer of Vaishali Pharma Limited from May 26, 2020. He has good experience in the field International Business Development as exposure to more than 90...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Chairman & MD | 16.5yrs | ₹6.43m | 18.73% ₹ 450.8m | |
| Chief Executive Officer | 4.4yrs | pas de données | pas de données | |
| Chief Financial Officer | 7.4yrs | ₹901.00k | pas de données | |
| Company Secretary & Compliance Officer | 2.8yrs | ₹504.00k | pas de données | |
| Whole Time Director | 14.9yrs | ₹1.61m | 5.62% ₹ 135.3m | |
| Executive Director | 3.2yrs | ₹1.16m | 0.000010% ₹ 240.7 | |
| Chief Operating Officer | no data | pas de données | 0.000010% ₹ 240.7 |
4.4yrs
Durée moyenne de l'emploi
43yo
Âge moyen
Gestion expérimentée: L'équipe de direction de VAISHALI est considérée comme expérimentée (ancienneté moyenne 4.3 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Chairman & MD | 16.5yrs | ₹6.43m | 18.73% ₹ 450.8m | |
| Whole Time Director | 16.5yrs | ₹1.61m | 5.62% ₹ 135.3m | |
| Executive Director | 6.5yrs | ₹1.16m | 0.000010% ₹ 240.7 | |
| Non Executive & Independent Director | 4.8yrs | ₹6.60k | pas de données | |
| Non-Executive & Independent Director | 4.8yrs | ₹6.60k | pas de données | |
| Non-Executive & Independent Director | 3.3yrs | ₹6.60k | pas de données |
5.7yrs
Durée moyenne de l'emploi
56.5yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de VAISHALI sont considérés comme expérimentés (ancienneté moyenne 5.5 ans).